Indoor aeroponic cultivation removes the environmental conditions that create each of these contamination categories. There is no soil, so there are no soil-borne heavy metals, no soil-borne pathogens, and no pesticide residues from agricultural activity. There are no adjacent fields, so there is no drift contamination.

Supplying a botanical extract for cosmetics or food supplements is one thing. Supplying a starting material for a human clinical trial is something entirely different. It requires an entirely different regulatory and operational framework: ✔️ Complete batch-to-batch consistency ✔️ Full traceability from plant genetics to final material ✔️ Validated analytical methods ✔️ Pharmacopoeial contaminant control ✔️ Compliance with GACP and pharmaceutical regulatory requirements